Sultan of Wall Street☕️📈
1.5K posts

Sultan of Wall Street☕️📈
@WallStSultan
Brewing long-term stocks & crypto | Sharing my positions & investment journey | Learning as I rule | NFA


Customer access should move at the same speed as innovation. When the healthcare industry works together to reach individuals, it does. Since last week, thousands of people have signed up for our Wegovy® waitlist. Starting today, eligible Hims & Hers customers can start their journeys with @novonordisk’s FDA-approved Wegovy® Pill & Wegovy® Pen and partner with their provider on a comprehensive weight loss program designed to help them achieve their goals. We take our role as the largest global consumer health platform seriously, and I can’t wait to keep finding ways to make sure everyone can access the tools they need to feel great. Read more below from Dr. Craig, our Head of Weight Loss, on what’s available today. (And if you’re starting your Wegovy journey with us today, tag me and tell me how it’s going!) More details, including important info, here: news.hims.com/newsroom/wegov…

What’s going on with $HIMS? After the $15 > $27 move (+57% in 5 days) on the $NVO news, the stock is simply cooling off. Moves that fast almost always lead to profit-taking from momentum traders, especially those who bought the breakout. At the same time, short sellers used the spike to reload positions which is why short interest remains extremely high at roughly ~85M shares (~40% of the float). In other words, the rally didn’t trigger a real covering wave. So what we’re seeing now is a typical consolidation phase. The stock is digesting the move, traders are repositioning, and both sides are fighting for control in the $23–27 range. The interesting part is that the positioning hasn’t changed much. Shorts didn’t exit and longs are still holding the fundamental story around the Novo partnership and future product expansion. With positioning still this crowded, $HIMS is essentially one major announcement away from the next leg higher.

I predict peptides will change everything re public health discourse for health & disease. B/c they’re closer to medications (in many cases actual medications!) than supplements but they entered the picture in supplement-like fashion. HRT went the other direction. Get educated.




Tom Lee: "I think it's still very likely that Bitcoin is going to be above 100K for year end and maybe even above $100K TO A NEW HIGH."






🚨 BITMINE JUST BOUGHT ANOTHER 50,000 ETH⁉️ 🔹 50,000 $ETH ($108.3M) 🔹 117,111 $ETH ($253.3M) in 48 hours 🔹 Acquired via FalconX 🔹 Spread across new wallets The wallets appear connected to Bitmine. TOM LEE isn’t slowing down. This is aggressive accumulation at scale. $ETH $BMNR
















